A Study to Evaluate Safety, Tolerability of LY4100511 (DC-853) in Healthy Asian and Non-Asian Participants
Clinical trial NCT06311656 · COMPLETED
Trial details
- NCT number
- NCT06311656
- Sponsor
- DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-19
- Primary completion
- 2024-10-04
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.